Related Experiment Video
Updated: Jun 30, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
A case of cardiogenic shock caused by capecitabine treatment
Andrew C Y To1, Khang Li Looi, Dragan Damianovich
1Green Lane Cardiovascular Service, Auckland City Hospital, Park Road, Grafton, Auckland 1023, New Zealand. andrewcyto@gmail.com
Background:
A 52-year-old woman underwent successful resection of stage IIB primary mucinous adenocarcinoma of the appendix and was started on capecitabine chemotherapy. Five days into the first course, after initially experiencing diarrhea, nausea, vomiting and a transient episode of retrosternal chest pain radiating to the left scapula, she presented to the emergency department with cardiogenic shock.
Investigations:
Electrocardiography, transthoracic echocardiography, laboratory investigation of cardiac biomarkers, coronary angiography and endomyocardial biopsy.
Diagnosis:
Capecitabine-induced cardiogenic shock.
Management:
Supportive treatment with dopamine, milrinone, norepinephrine (noradrenaline) and levosimendan.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care